Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

TY - JOUR

T1 - Guidelines for the diagnosis and management of food allergy in the United States

T2 - Summary of the NIAID-Sponsored Expert Panel Report

AU - Boyce, Joshua A.

AU - Assa'a, Amal

AU - Burks, A. Wesley

AU - Jones, Stacie M.

AU - Sampson, Hugh A.

AU - Wood, Robert A.

AU - Plaut, Marshall

AU - Cooper, Susan F.

AU - Fenton, Matthew J.

AU - Arshad, S. Hasan

AU - Bahna, Sami L.

AU - Beck, Lisa A.

AU - Byrd-Bredbenner, Carol

AU - Camargo, Carlos A.

AU - Eichenfield, Lawrence

AU - Furuta, Glenn T.

AU - Hanifin, Jon M.

AU - Jones, Carol

AU - Kraft, Monica

AU - Levy, Bruce D.

AU - Lieberman, Phil

AU - Luccioli, Stefano

AU - McCall, Kathleen M.

AU - Schneider, Lynda C.

AU - Simon, Ronald A.

AU - Simons, F. Estelle R.

AU - Teach, Stephen J.

AU - Yawn, Barbara P.

AU - Schwaninger, Julie M.

N1 - Funding Information: J. A. Boyce has served on the Advisory Board of GlaxoSmithKline. He has served as a, consultant and/or speaker for Altana, GlaxoSmithKline, and Merck. He has received, funding/grant support from the National Institutes of Health . Funding Information: A. W. Burks holds, or is listed as an inventor on, multiple US patents related to food allergy. He owns stock in Allertein and MastCell, Inc, and is a minority stockholder in Dannon Co Probiotics. He has served as a consultant for ActoGeniX NV, McNeil Nutritionals, Mead Johnson, and Novartis. He has served on the speaker’s bureau for EpiPen/Dey, LP, and has served on the data monitoring committee for Genentech. He has served on an expert panel for Nutricia. Dr Burks has received funding/grant support from the Food Allergy and Anaphylaxis Network, Gerber, Mead Johnson, and the National Institutes of Health . Funding Information: S. M. Jones has served as a speaker and grant reviewer and has served on the medical advisory committee for the Food Allergy and Anaphylaxis Network. She has received funding/grant support from Dyax Corp, the Food Allergy and Anaphylaxis Network, Mead Johnson, the National Peanut Board, and the National Institutes of Health . Funding Information: R. A. Wood has served as a speaker/advisory board member for GlaxoSmithKline, Merck, and Dey. He has received funding/grant support from Genentech and the, National Institutes of Health (National Institute of Allergy and Infectious Diseases). Funding Information: S. H. Arshad has received funding/grant support from the National Institutes of Health and the National Institute of Health Research, UK . Funding Information: L. A. Beck has received funding/grant support from the American Academy of Allergy, Asthma, and Immunology, the National Eczema Association, and the National Institutes of Health . Funding Information: C. Byrd-Bredbenner owns stock in Johnson & Johnson. She has received funding/grant support from the US Department of Agriculture, the Canned Food Alliance, and the New Jersey Department of Health and Senior Services . Funding Information: G. T. Furuta has served as a consultant and/or speaker to Ception Therapeutics and TAP. He has received funding/grant support from the American Gastrointestinal Association and the National Institutes of Health . Funding Information: M. Kraft has served as a consultant and/or speaker for Astra-Zeneca, Genentech, GlaxoSmithKline, Merck, Novartis, and Sepracor. She has received funding/grant support from Genentech, GlaxoSmithKline, the National Institutes of Health and Novartis . Funding Information: B. D. Levy holds, or is listed as an inventor on, US patent applications #20080064746 entitled ‘‘Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases’’ and #20080096961 entitled ‘‘Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma.’’ He owns stock in Resolvyx Pharmaceuticals. He has served as a consultant for Bayer Healthcare and Resolvyx Pharmaceuticals. Dr Levy has received funding/grant support from the National Institutes of Health . Funding Information: L. C. Schneider has served as a consultant/clinical advisor for the Food Allergy Initiative. She has received funding/grant support from a variety of not-for-profit research foundations, as well as Novartis and the National Institutes of Health. Funding Information: F. E. R. Simons holds a patent on ‘‘Fast-disintegrating epinephrine tablets for sublingual administration.’’ She is a past-president of the American Academy of Allergy, Asthma and Immunology and of the Canadian Society of Allergy and Clinical Immunology. She is a member of the advisory boards of Dey, Intelliject, and ALK-Abello. She has received funding/grant support from AllerGen, the Canadian Allergy, Asthma and Immunology Foundation/Anaphylaxis Canada, and the Canadian Institutes of Health, Research . Funding Information: S. J. Teach has served as a speaker for AstraZeneca. He has received funding/grant support from the AstraZeneca Foundation, Aventis, the Child Health Center Board, the CNMC Research Advisory Council, the National Association of Chain Drug Stores Foundation, the National Institutes of Health (National Institute of Allergy and Infectious, Diseases; National Heart, Lung, and Blood Institute), Novartis/Genentech, the Robert Woods Johnson Foundation, the US Centers for Disease Control and Prevention, the US Public Health Service, and the Washington, DC, Department of Health .

PY - 2011/2

Y1 - 2011/2

UR - http://www.scopus.com/inward/record.url?scp=78650812047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650812047&partnerID=8YFLogxK

U2 - 10.1016/j.nut.2010.12.001

DO - 10.1016/j.nut.2010.12.001

M3 - Article

C2 - 21215925

AN - SCOPUS:78650812047

VL - 27

SP - 253

EP - 267

JO - Nutrition

JF - Nutrition

SN - 0899-9007

IS - 2

ER -